(19)
(11) EP 3 065 422 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
12.06.2019 Bulletin 2019/24

(45) Mention of the grant of the patent:
24.04.2019 Bulletin 2019/17

(21) Application number: 16158768.8

(22) Date of filing: 04.03.2016
(51) International Patent Classification (IPC): 
H04R 25/00(2006.01)

(54)

TECHNIQUES FOR INCREASING PROCESSING CAPABILITY IN HEAR AIDS

TECHNIKEN ZUR VERBESSERUNG DER VERARBEITUNGSFÄHIGKEIT IN HÖRGERÄTEN

TECHNIQUES PERMETTANT D'AMÉLIORER LA CAPACITÉ DE TRAITEMENT DES AIDES AUDITIVES

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 04.03.2015 US 201562128097 P

(43) Date of publication of application:
07.09.2016 Bulletin 2016/36

(73) Proprietor: Starkey Laboratories, Inc.
Eden Prairie, MN 55344 (US)

(72) Inventors:
  • Woods, William S.
    Berkeley, CA 94706 (US)
  • McKinney, Martin
    Minneapolis, MN 55410 (US)
  • Zhang, Tao
    Eden Prairie, MN 55344 (US)
  • Merk, Ivo Leon Diane Marie
    Eden Prairie, MN 55347 (US)

(74) Representative: Dentons UK and Middle East LLP 
One Fleet Place
London EC4M 7WS
London EC4M 7WS (GB)


(56) References cited: : 
EP-A1- 1 801 786
WO-A1-2012/066149
 EP-A1- 2 819 436
US-A- 5 680 467
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).